申请人:Eisai R&D Management Co., Ltd.
公开号:EP2039361A2
公开(公告)日:2009-03-25
The present invention is directed to methods of treating diseases and disorders related to immune responses by administering one or more immunomodulatory compounds. In particular, the invention is directed to methods of stimulating and reducing immune responses, treating autoimmune conditions, treating allergic reactions and asthma, and preventing ischemic damage and asthma by administering one or more immunomodulatory compounds.
本发明涉及通过施用一种或多种免疫调节化合物治疗与免疫反应有关的疾病和失调的方法。特别是,本发明涉及通过施用一种或多种免疫调节化合物来刺激和减少免疫反应、治疗自身免疫疾病、治疗过敏反应和哮喘以及预防缺血性损伤和哮喘的方法。